Stocks to Buy: A new listing has become Jefferies' latest 'high-conviction top pick'; Check upside targets
- Jefferies named Molbio Diagnostics its latest high-conviction top pick
- The company has commercialized a point-of-care molecular diagnostics platform
- Molbio’s diagnostics business is relevant to Indian healthcare investors